Literature DB >> 9261140

Structural and functional requirements for agonist-induced internalization of the human platelet-activating factor receptor.

C Le Gouill1, J L Parent, M Rola-Pleszczynski, J Stanková.   

Abstract

The receptor for platelet-activating factor (PAF) is a member of the G-protein-coupled receptor family. To study the structural elements and mechanisms involved in the internalization of human PAF receptor (hPAFR), we used the following mutants: a truncated mutant in the C-terminal tail of the receptor (Cys317 --> Stop) and mutations in the (D/N)P(X)2,3Y motif (Asp289 --> Asn,Ala and Tyr293 --> Phe,Ala). Chinese hamster ovary cells expressing the Cys317 --> Stop mutant exhibited a marked reduction in their capacity to internalize PAF, suggesting the existence of determinants important for endocytosis in the last 26 amino acids of the cytoplasmic tail. Substitution of Asp289 to alanine abolished both internalization and G-protein coupling, whereas substitution of Tyr293 to alanine abolished coupling but not internalization. Inhibition or activation of protein kinase C did not significantly affect the internalization process. Receptor sequestration and ligand uptake was, at least in part, blocked by concanavalin A and blockers of endocytosis mediated by clathrin-coated pits. Our data suggest that the internalization of a G-protein-coupled receptor and coupling to a G-protein can be two independent events. Moreover, the C terminus tail of hPAFR, but not the putative internalization motifs, may be involved in the internalization of hPAFR.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261140     DOI: 10.1074/jbc.272.34.21289

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  A single amino acid substitution (N297A) in the conserved NPXXY sequence of the human N-formyl peptide receptor results in inhibition of desensitization and endocytosis, and a dose-dependent shift in p42/44 mitogen-activated protein kinase activation and chemotaxis.

Authors:  J M Gripentrog; A J Jesaitis; H M Miettinen
Journal:  Biochem J       Date:  2000-12-01       Impact factor: 3.857

2.  The delta e13 isoform of the calcitonin receptor forms a six-transmembrane domain receptor with dominant-negative effects on receptor surface expression and signaling.

Authors:  Thomas Seck; Maria Pellegrini; Ana Maria Florea; Veronique Grignoux; Roland Baron; Dale F Mierke; William C Horne
Journal:  Mol Endocrinol       Date:  2005-04-28

3.  Rescue of internalization-defective platelet-activating factor receptor function by EBP50/NHERF1.

Authors:  Denis J Dupré; Marek Rola-Pleszczynski; Jana Stankova
Journal:  J Cell Commun Signal       Date:  2012-08-10       Impact factor: 5.782

Review 4.  Microbial uptake by the respiratory epithelium: outcomes for host and pathogen.

Authors:  Margherita Bertuzzi; Gemma E Hayes; Elaine M Bignell
Journal:  FEMS Microbiol Rev       Date:  2019-03-01       Impact factor: 16.408

5.  Amantadine inhibits platelet-activating factor induced clathrin-mediated endocytosis in human neutrophils.

Authors:  Phillip C Eckels; Anirban Banerjee; Ernest E Moore; Nathan J D McLaughlin; Lynn M Gries; Marguerite R Kelher; Kelly M England; Fabia Gamboni-Robertson; Samina Y Khan; Christopher C Silliman
Journal:  Am J Physiol Cell Physiol       Date:  2009-03-18       Impact factor: 4.249

6.  Regulation of platelet-activating factor-mediated protein tyrosine phosphatase 1B activation by a Janus kinase 2/calpain pathway.

Authors:  Geneviève Hamel-Côté; Daniel Gendron; Marek Rola-Pleszczynski; Jana Stankova
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

7.  Regulation of platelet-activating factor-mediated interleukin-6 promoter activation by the 48 kDa but not the 45 kDa isoform of protein tyrosine phosphatase non-receptor type 2.

Authors:  Geneviève Hamel-Côté; Fanny Lapointe; Steeve Véronneau; Marian Mayhue; Marek Rola-Pleszczynski; Jana Stankova
Journal:  Cell Biosci       Date:  2019-06-25       Impact factor: 7.133

8.  Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lung.

Authors:  Kim S LeMessurier; Hans Häcker; Liying Chi; Elaine Tuomanen; Vanessa Redecke
Journal:  PLoS Pathog       Date:  2013-11-07       Impact factor: 6.823

9.  Nuclear localization of platelet-activating factor receptor controls retinal neovascularization.

Authors:  Vikrant K Bhosle; José Carlos Rivera; Tianwei Ellen Zhou; Samy Omri; Melanie Sanchez; David Hamel; Tang Zhu; Raphael Rouget; Areej Al Rabea; Xin Hou; Isabelle Lahaie; Alfredo Ribeiro-da-Silva; Sylvain Chemtob
Journal:  Cell Discov       Date:  2016-07-12       Impact factor: 10.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.